Butobarbital
Systematic (IUPAC) name | |
---|---|
5-Butyl-5-ethyl-1,3-diazinane-2,4,6-trione | |
Clinical data | |
Trade names | Soneryl |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
CAS Number | 77-28-1 |
ATC code | N05CA03 (WHO) |
PubChem | CID 6473 |
DrugBank | DB01353 |
ChemSpider | 6229 |
UNII | OHZ8QAW6YC |
KEGG | D02618 |
ChEMBL | CHEMBL404422 |
Chemical data | |
Formula | C10H16N2O3 |
Molar mass | 212.246 g/mol |
| |
| |
(verify) |
Butobarbital (BAN), also called butobarbitone or butethal, Soneryl, and Neonal,[1] is a hypnotic drug which is a barbiturate derivative. It was developed by Poulenc Brothers (now part of Rhône Poulenc) in 1921.[2]
References
- ↑ International Drug Names
- ↑ DE Patent 481129
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.